· new research indicates that popular weight-loss and diabetes medications, semaglutide and tirzepatide, may offer … · a retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and … 95% confidence interval [ci], 0. 50–0. 81), … The findings aim to optimize the … · glp-1 ras used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs … · accordingly, many guidelines now recommend the addition of glp-1ras to ongoing antihyperglycemic regimens to lower the risk of stroke in type 2 diabetes. This systematic review and meta-analysis investigated the impact of glp-1 ras on stroke risk. · for clinical practice, glp-1ras may be a particularly attractive treatment option in patients with type 2 diabetes and obesity … · glp-1 ra users had significantly lower risks of dementia (hazard ratio [hr], 0. 63;
The Glp 1 Ra Surprise Unexpected Protection Against Stroke And Neurodegeneration
· new research indicates that popular weight-loss and diabetes medications, semaglutide and tirzepatide, may offer … · a retrospective cohort study found that semaglutide and...
